MPR CME

CME/CE

CME/CE Courses


Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.


Featured Courses

Bridging the Gap in the Diagnosis and Management of Postmenopausal Osteoporosis

Bridging the Gap in the Diagnosis and Management of Postmenopausal Osteoporosis

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, CPEU Credit
New guidelines that incorporate all the available treatment options for postmenopausal osteoporosis have been recently published, however, diagnosis and treatment gaps may persist, as questions remain about the risk assessment, diagnostic interpretation, as well as therapy selection, monitoring, and appropriate switching or tapering off.
Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis

Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
In this CME Outfitters Live and OnDemand activity, expert faculty will focus on assessment, treatment, and management strategies to provide patients with the best treatment aligned with evolving evidence and expert recommendations.
Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management

Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
This activity provides an overview of the role of the innate and adaptive immune systems in the development and progression of multiple sclerosis (MS), while exploring the therapeutic implications of immune dysfunction. MS immunotherapies are reviewed, with a focus on their mechanisms of action and immune-related toxicities. Patient case studies are included to illustrate considerations in the selection and sequencing of therapy and the management of immune-related toxicities.
When is Switching ART Necessary?

When is Switching ART Necessary? | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
In this CME Outfitters BriefCase, faculty will highlight a patient case that focuses on seizing opportunities to optimize and simplify treatment for patients with human immunodeficiency virus (HIV) while maintaining virologic suppression, as well as best practices for engaging patients in shared decision-making so that patient preference is always considered.
The Role of Maintenance Therapy in AML

The Role of Maintenance Therapy in AML | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
As the research of maintenance strategies in acute myeloid leukemia (AML) advances, it is important for clinicians stay abreast of study designs and results from clinical trials. This activity will discuss a patient case study and explain treatment decisions and rationale for maintenance strategies in AML.
Next-Generation S1P Modulators in MS Management

Next-Generation S1P Modulators: Clinical Implications of Higher Selectivity in MS Management | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
Multiple sclerosis (MS) management requires balancing the benefits of medications aimed at inhibiting inflammation and immunosuppression or immunomodulation against the risks of serious adverse effects and other drawbacks, such as the inconvenience and discomfort of infusions or injections. In this roundtable discussion, 2 experts in MS management review current and investigational treatments with a focus on newer sphingosine 1-phosphate (S1P) receptor modulators.
Approaching the Contemplative Patient with Alcohol Use Disorder

Approaching the Contemplative Patient with Alcohol Use Disorder | myCME

AMA PRA Category 1 Credit(s)TM, AAPA Category I CME credit, ANCC Contact Hour(s), CE for Pharmacists
Alcohol use disorder (AUD) is a significant public health issue in the United States, responsible for 88,000 deaths and costs of $223.5 billion annually. Despite the gravity of this disorder, many with AUD do not think their drinking is a serious problem. Addiction experts discuss messages that resonate with individuals who do not see their drinking as a problem, the myth of needing to “hit bottom” before seeking treatment, and strategies for managing patients with AUD.

More

HCM: Breakthrough Treatments Targeting Novel Mechanisms

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder that involves unexplained left ventricular (LV) hypertrophy, often caused by pathogenic variants in sarcomere genes.

Unmet Needs in Current Treatment Approaches for HCM

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
This CMEO Snack highlights the recommendations from the 2020 AHA/ACC Guidelines for the Diagnosis and Treatment of Patients with HCM, including the importance of multidisciplinary care and new agents that have the potential to improve care and outcomes of patients with HCM.

Promoting Recognition, Diagnosis and Treatment of CAD

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
In this activity, Catherine M. Broome, MD, and Alexander Röth, MD, provide an understanding of the pathogenesis of Cold Agglutinin Disease (CAD) caused by cold-reacting IgM autoantibodies and reveal common clinical features.

Animated Rhythms Course (6 hrs Cat I CME/CE) | myCME

AMA PRA Category 1 Credit(s)TM, CE for Nurses
Cover all of the common ECG rhythms you will encounter in your practice. All 26 rhythm patterns are presented with animation to correlate the electrical path through the heart to the tracing on the rhythm strip. Ideal for preparation for Advanced Cardiovascular Life Support (ACLS) certification, board review, or recertification. Learn more and view a course outline.

50 Online ECG Case Studies (13 hrs Cat I CME/CE) | myCME

AMA PRA Category 1 Credit(s)TM, CE for Nurses
Choose the 50 Case Studies Course for an excellent review of 12-lead ECG and Rhythm interpretation. Cover 50 12-Lead ECG tracings with clinical discussions and quizzes. Topics include: STEMI, non-STEMI, Bundle Branch Blocks, WPW, LVH, WPW as well as common rhythm abnormalities. Learn more and view a course outline.

12-Lead ECG Course (30 hrs Cat I CME/CE) | myCME

AMA PRA Category 1 Credit(s)TM, CE for Nurses
Learn to analyze, not memorize, with The 12-Lead ECG Course. A hybrid of online material and written material, this course is made for flexible home/self-study. Review the normal pattern, STEMI, nonSTEMI, Bundle Branch Blocks, LAFB, LVH, and WPW and ultimately learn how to analyze changes associated with acute MI/ischemia. Learn more and view a course outline.

New Strategies for Primary Postpartum Hemorrhage and Abnormal Postpartum Uterine Bleeding | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
This activity will discuss the significance of PPH, blood-loss assessment techniques, novel strategies for management, and frequently asked clinical questions.

Lipid Management in Very High-Risk Patients Post-MI

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists, CPEU Credit
During this enduring symposium, experts will provide guidance on the clinical application of statin and nonstatin therapies in this setting, as well as information about new and emerging studies that can further inform patient selection in order to optimize outcomes.

Racial and Genetic Implications for MS Treatment Selection

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
This online session will explore differences in the prevalence and incidence of Multiple Sclerosis based on gender and race, as well as the implications for treatment selection and management of side effects.

HCM Defined, HCM Revealed

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
The first installment in this CME Outfitters Snack series on HCM focuses on recognizing the array of presenting symptoms of HCM in order to facilitate an accurate diagnosis and referral, including the utilization of guideline recommendations for diagnostic assessment and risk stratification.